Top Markets
Coin of the day
TME Pharma N.V. TME Pharma N.V.

TME Pharma N.V.

ALTME
Clasificación en acciones #33661
TME Pharma N.V., a biopharmaceutical company in the clinical development stage... TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.
Precio por acción
$0.07591393
Última sincronización: 2026-08-14
Capitalización bursátil
$7.15M
Cambio (1 día)
3.90%
Cambio (1 año)
-41.05%
País
DE
Comercio TME Pharma N.V. (ALTME)

Categoría

Historial del precio de la acción de TME Pharma N.V. (ALTME)
Precio más alto de cierre: $0.07 el 2026-08-01

Precio más bajo de cierre: $2.42K el 2016-09-01
Historial del precio de la acción de TME Pharma N.V. desde 2016 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 32.43%
2025 -15.09%
2024 -67.73%
2023 -81.54%
2022 -95.65%
2021 -45.73%
2020 27.62%
2019 -67.02%
2018 -81.06%
2017 -65.91%
2016 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE